Close Menu
Home › Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Food Allergy Dx Firm AllerGenis, Luminex Ink Test Development Deal

Jan 16, 2019
|
staff reporter

NEW YORK (360Dx) – Food allergy diagnostic developer AllerGenis today announced a non-exclusive deal with Luminex for use of that company's xMAP technology to develop, market, and sell a precision food allergy diagnostic assay.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Immunoassays

  1. Ortho Clinical Diagnostics Receives CE Mark for Enhanced Cardiac Assay

  2. Bio-Techne, Uman Diagnostics Ink License, Supply Agreement for Neurofilament Light Assay

  3. Life Sciences, Diagnostics Drive Danaher Q2 Revenues Up 4 Percent

  4. Abbott Q2 Diagnostics Revenues Rise 2 Percent, MDx Revenues Down 12 Percent

  5. Chembio Diagnostics, Shire Human Genetic Therapies Collaborate to Develop POC Biomarker Test

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.